标题 |
Lung-MAP S1800D: A phase II/III study of N-803 (ALT-803) plus pembrolizumab versus standard of care in participants with stage IV or recurrent non-small cell lung cancer (NSCLC) previously treated with anti-PD-1 or antiPD-L1 therapy
Lung-MAP S1800D:一项在既往接受过抗PD-1或抗PD-L1治疗的IV期或复发性非小细胞肺癌(NSCLC)参与者中进行的N-803(ALT-803)联合派姆单抗与标准治疗对比的II/III期研究
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | JCO. 2024;42(16_suppl):2619–2619. |
求助人 | |
下载 | 暂无链接,等待应助者上传 |